| 000 | 01597 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516073818.0 | ||
| 264 | 0 | _c20120504 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1521-0103 | ||
| 024 | 7 |
_a10.1124/jpet.111.190173 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhou, Xin | |
| 245 | 0 | 0 |
_aRole of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cApr 2012 |
||
| 300 |
_a233-41 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xchemically induced |
| 650 | 0 | 4 | _aAdenocarcinoma of Lung |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xdeficiency |
| 650 | 0 | 4 |
_aBiotransformation _xdrug effects |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2A6 |
| 650 | 0 | 4 | _aCytochrome P450 Family 2 |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 |
_aLung Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
| 650 | 0 | 4 |
_aNitrosamines _xmetabolism |
| 650 | 0 | 4 |
_aPyridines _xmetabolism |
| 650 | 0 | 4 |
_aTissue Distribution _xdrug effects |
| 700 | 1 | _aD'Agostino, Jaime | |
| 700 | 1 | _aXie, Fang | |
| 700 | 1 | _aDing, Xinxin | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 341 _gno. 1 _gp. 233-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.111.190173 _zAvailable from publisher's website |
| 999 |
_c21477988 _d21477988 |
||